BlackRock built a massive business around exchange-traded funds. The company's current focus is to build out its private markets business, which could be a much more profitable opportunity.
BlackRock (BLK) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
The latest trading day saw BlackRock (BLK) settling at $980.38, representing a +1.96% change from its previous close.
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does BlackRock (BLK) have what it takes?
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Investors interested in Financial - Investment Management stocks are likely familiar with Affiliated Managers Group (AMG) and BlackRock (BLK). But which of these two stocks is more attractive to value investors?
BlackRock (BLK) closed at $971.92 in the latest trading session, marking a -1.09% move from the prior day.
Over the quarter, the BlackRock Health Sciences Term Trust increased its exposure to pharmaceuticals and biotechnology firms. Within the pharmaceuticals subsector, the Trust initiated positions in GSK and Vertex Pharmaceuticals, due to positive fundamentals and progress in a rare disease program, respectively. Elsewhere, the Trust reduced its exposure to medical devices & supplies companies, which included locking in profits.
BlackRock (NYSE: BLK) is paying its latest quarterly dividend today, June 23, rewarding shareholders with a cash distribution of $5.73 per share.
BLK is cutting nearly 200 jobs, under 1% of staff, as it balances acquisition-driven growth, private market expansion and efficiency goals.
Bitcoin's (BTC) plunge and subsequent correction in June have sparked renewed optimism regarding the cryptocurrency's next moves but also a debate about whether the digital asset has found its cycle bottom.
SpaceX's blockbuster IPO rally is fueling investor excitement. Here are three leveraged ETFs offering amplified exposure to the stock's momentum.